Literature DB >> 28405721

Genome editing: a robust technology for human stem cells.

Arun Pandian Chandrasekaran1, Minjung Song2, Suresh Ramakrishna3,4.   

Abstract

Human pluripotent stem cells comprise induced pluripotent and embryonic stem cells, which have tremendous potential for biological and therapeutic applications. The development of efficient technologies for the targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. Genome editing of stem cells is possible with the help of synthetic nucleases that facilitate site-specific modification of a gene of interest. Recent advances in genome editing techniques have improved the efficiency and speed of the development of stem cells for human disease models. Zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system are powerful tools for editing DNA at specific loci. Here, we discuss recent technological advances in genome editing with site-specific nucleases in human stem cells.

Entities:  

Keywords:  Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system; Embryonic stem cells; Induced pluripotent stem cells; Transcription activator-like effector nucleases; Zinc finger nucleases

Mesh:

Substances:

Year:  2017        PMID: 28405721     DOI: 10.1007/s00018-017-2522-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  131 in total

1.  A method for genetic modification of human embryonic stem cells using electroporation.

Authors:  Magdaline Costa; Mirella Dottori; Koula Sourris; Pegah Jamshidi; Tanya Hatzistavrou; Richard Davis; Lisa Azzola; Steven Jackson; Sue Mei Lim; Martin Pera; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

2.  Targeted gene replacement in Drosophila via P element-induced gap repair.

Authors:  G B Gloor; N A Nassif; D M Johnson-Schlitz; C R Preston; W R Engels
Journal:  Science       Date:  1991-09-06       Impact factor: 47.728

Review 3.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

Review 4.  Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.

Authors:  Michael Boettcher; Michael T McManus
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes.

Authors:  Ting Li; Sheng Huang; Xuefeng Zhao; David A Wright; Susan Carpenter; Martin H Spalding; Donald P Weeks; Bing Yang
Journal:  Nucleic Acids Res       Date:  2011-03-31       Impact factor: 16.971

7.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Authors:  Kosuke Yusa; S Tamir Rashid; Helene Strick-Marchand; Ignacio Varela; Pei-Qi Liu; David E Paschon; Elena Miranda; Adriana Ordóñez; Nicholas R F Hannan; Foad J Rouhani; Sylvie Darche; Graeme Alexander; Stefan J Marciniak; Noemi Fusaki; Mamoru Hasegawa; Michael C Holmes; James P Di Santo; David A Lomas; Allan Bradley; Ludovic Vallier
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

8.  CRISPR interference directs strand specific spacer acquisition.

Authors:  Daan C Swarts; Cas Mosterd; Mark W J van Passel; Stan J J Brouns
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.

Authors:  Fei Xie; Lin Ye; Judy C Chang; Ashley I Beyer; Jiaming Wang; Marcus O Muench; Yuet Wai Kan
Journal:  Genome Res       Date:  2014-08-05       Impact factor: 9.043

10.  Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.

Authors:  Jianbin Wang; Colin M Exline; Joshua J DeClercq; G Nicholas Llewellyn; Samuel B Hayward; Patrick Wai-Lun Li; David A Shivak; Richard T Surosky; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2015-11-09       Impact factor: 54.908

View more
  2 in total

Review 1.  Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.

Authors:  Hatice Burcu Şişli; Taha Bartu Hayal; Selin Seçkin; Selinay Şenkal; Binnur Kıratlı; Fikrettin Şahin; Ayşegül Doğan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Two decades of embryonic stem cells: a historical overview.

Authors:  C Eguizabal; B Aran; S M Chuva de Sousa Lopes; M Geens; B Heindryckx; S Panula; M Popovic; R Vassena; A Veiga
Journal:  Hum Reprod Open       Date:  2019-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.